Global 3D Bioprinting Market - By Technology , Geography, Trends, Forecast - 2017 - 2022

  • ID: 4388539
  • Report
  • Region: Global
  • 136 pages
  • Mordor Intelligence
1 of 3
The Global 3D Bioprinting market is valued at USD XX.XX billion in 2016 and is expected to reach a value of USD XX.XX billion by the end of 2022, growing at a projected CAGR of XX.XX% during the forecast period of 2017 - 2022. Medicine evolves almost spontaneously. Companies like Organovo, which is printing human tissue with the help of 3D printers developed in collaboration with Invetech will lead us into the future of medicine. As this technology advances, synthetic body organs and artificial tissues will become a reality in future.

Organovo, which is a 3D bioprinting technology-centric company, recently presented data on creating a three-dimensional kidney tissue at the 2015 Experimental Biology conference in Boston, Massachusetts. This company always keeps coming up with astonishing developments with the help of this technology.

The only difference in this method of 3D printing lies in the type of ink used. The ink could be made of a single element or an assortment of various materials ranging from living cells to semiconductors. The final product from this procedure is made of better predictive values and possesses higher clinical relevance.

The current engineering techniques have made integrating mechanical properties, such as electrical conductivity or optical traits into the 3D materials very easy. These materials can now recognize and respond to their surrounding environment. This report deals with the present 3D bioprinting market and the promise, the sheer potential, which it holds for the future. The report also provides key insights into strategies and solutions of key market leaders like Organovo, EnvisionTEC and Bio3D Technologies.


Organ transplants for the one really in need is driving this market largely.

The demands for 3D bioprinting market is expected to grow even more.


The current global market for the 3D bioprinting technology is still in its nascent stages and has the tendency of facing few ups and downs.

This technology is quite expensive too.


The report covers the entire market in five parts:

Section 1 is introductory and Section 2 gives an overview of the 3D bioprinting market. It delves into the technology snapshot, drivers, restraints and growth prospects of the industry.

Sections 3 and 4 break down the market by industries and regions and analyze the growth, trends and forecasts. The report also focuses on market share of major players their products and services along with our analysts' views of the market. This is done in order to give a complete overview of the market to the reader and draw his or her own conclusions about the market.

Section 5 deals with the competition among 3D bioprinting solution vendors and comparison of their products. This section identifies the growth strategies adopted by some of the most active companies in this industry.

Section 6 analyzes key challengers in this market while Section 7 tells about the role played by business accelerators, mergers and acquisitions that have happened over the last year and the investment firms which are investing in this domain.

The last section gives a glimpse into what the future of the industry would be five years from now. It includes answers to questions like, what policies would impact the market most, what growth strategies would be most successful, etc.
Note: Product cover images may vary from those shown
2 of 3
1. Introduction
1.1 Research Methodology
1.2 Key Findings
2. Executive Summary
3. Current Market Trends
3.1 Market Overview
3.2 Technology Snapshot
3.3 Factors Driving the Market
3.4 Factors Restraining the Market
4. 3D Culture Scaffold Vendor Profiles
4.1 3D Biotek
4.1.1 Company Overview
4.1.2 Products and Services
4.1.3 Analyst View
4.2 Reinnervate Ltd
4.2.1 Company Overview
4.2.2 Products and Services
4.2.3 Analyst View
4.3 Life Technologies
4.3.1 Company Overview
4.3.2 Products and Services
4.3.3 Analyst View
4.4 SCIVAX Corporation
4.4.1 Company Overview
4.4.2 Products and Services
4.4.3 Analyst View
4.5 Nanofiber Solutions
4.5.1 Company Overview
4.5.2 Products and Services
4.5.3 Analyst View
4.6 The Electrospinning Company Ltd
4.6.1 Company Overview
4.6.2 Products and Services
4.6.3 Analyst View
4.7 Matricel
4.7.1 Company Overview
4.7.2 Products and Services
4.7.3 Analyst View
4.8 Insphero
4.8.1 Company Overview
4.8.2 Products and Services
4.8.3 Analyst View
4.9 Boca Scientific, Inc.
4.9.1 Company Overview
4.9.2 Products and Services
4.9.3 Analyst View
4.10 GeSim
4.10.1 Company Overview
4.10.2 Products and Services
4.10.3 Analyst View
5. 3D Cell/Tissue Printing Companies
5.1 Organavo
5.1.1 Company Overview
5.1.2 Products and Services
5.1.3 Analyst View
5.2 OxSyBio
5.2.1 Company Overview
5.2.2 Products and Services
5.2.3 Analyst View
5.3 Aspect Biosystems
5.3.1 Company Overview
5.3.2 Products and Services
5.3.3 Analyst View
5.4 EnvisionTec
5.4.1 Company Overview
5.4.2 Products and Services
5.4.3 Analyst View
5.5 Nano3D Biosciences, Inc.
5.5.1 Company Overview
5.5.2 Products and Services
5.5.3 Analyst View
5.6 Rainbow Coral Corp.
5.6.1 Company Overview
5.6.2 Products and Services
5.6.3 Analyst View
5.7 3D Bio printing Solutions
5.7.1 Company Overview
5.7.2 Products and Services
5.7.3 Analyst View
5.8 TeVido
5.8.1 Company Overview
5.8.2 Products and Services
5.8.3 Analyst View
6. Road Ahead for 3D Bioprinting Market
7. Investment Analysis
7.1 Role of Business Accelerators
7.2 Investment Firms Strategies and Recent Investments
8. Future of 3D Bioprinting
9 List of Tables
10 List of Figures
11 Abbreviations
12 Works Cited
13 Disclaimer
Note: Product cover images may vary from those shown
3 of 3


4 of 3
Note: Product cover images may vary from those shown